We agree with the Editorial in the July, 2020, issue of The Lancet Gastroenterology & Hepatology, which emphasised the concerning long-term implications of lockdowns implemented to flatten the epidemic curve of COVID-19 on the health behaviour of individuals with alcohol-use disorder.1 A complex interplay of heightened financial difficulties, social isolation, uncertainty about the future, and…
Yusuke Shimakawa (Institut Pasteur) discusses the development and evaluation of a simple score for hepatitis B treatment eligibility in Africa.Read the full article:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00449-1?dgcid=buzzsprout_icw_podcast_generic_langas
The headline figures from WHO’s 2024 Global Hepatitis Report, released at the World Hepatitis Summit in Lisbon, Portugal, on April 9, make for stark reading.…
The headline figures from WHO’s 2024 Global Hepatitis Report, released at the World Hepatitis Summit in Lisbon, Portugal, on April 9, make for stark reading.…
Study identified factors and strategies for maintaining response
Adults newly diagnosed with active Crohn’s disease benefit from immediate treatment with advanced therapies, according to research.
A new study suggests that certain dietary changes may be more effective than medication.
Both a special diet that excludes “FODMAP” compounds and a low-carb high-fibre diet were effective
Two 4-week dietary interventions and optimised medical treatment reduced the severity of IBS symptoms, with a larger effect size in the diet groups. Dietary interventions…
Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy. Portal hypertension…
Although the past 10 years have brought a wave of novel medications and mechanisms to the management of Crohn’s disease and inflammatory bowel disease (IBD),…
